Cardiac Design Labs
Telemetric Patient Monitoring System
CURRENT IMPACT
As of August 2023
700 +
Devices deployed in different states
32
devices deployed in 8 Composite Hospitals of Border Security Forces (BSF)
6200+
patients directly monitored using Padma Vitals devices
Geographical Focus
- PAN India
Potential Impact
- Reach
200,000
lives
SAMRIDH has been a key partner in our efforts to scale-up Padma Vitals across the length and breadth of India, particularly to enhance its access for vulnerable communities. The support received through the initiative enabled us in timely deployment of Padma Vitals devices and improvement in the product outreach. This collaboration has set us on the path to achieve financial sustainability in the long run.
Samridh support
SAMRIDH’s financial assistance is enabling CDL to manufacture and deploy 2,500 Padma Vitals / Padma Rhythms devices at district level hospitals, community health centers, and primary health centers. The enhanced sales have helped CDL to generate the required cash flows to support its operations and manufacture additional devices that will be deployed in hospitals located in tier 2 and 3 cities. SAMRIDH has further been catalytic in augmenting CDL’s business capabilities by strengthening its marketing and sales effort towards reaching out to potential partners and customers for demos and trials. This has led CDL to achieve a leverage of 11.9x on the financial assistance received from SAMRIDH. In addition, SAMRIDH has also supported CDL through different business advisory services which led to better positioning of their devices in different markets and further market penetration of the product in unique and remote geographies.